Impact of PACV Administration on Vaccine Hesitancy

NCT04450940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1705

Last updated 2020-06-30

No results posted yet for this study

Summary

Our objective is to assess the impact of administering the PACV to parents of newborns. We also sought to assess the prevalence of vaccine hesitancy among parents of newborns in Houston, TX and to characterize the demographics of vaccine-hesitant parents.

Conditions

  • Evaluating Impact of PACV on Vaccine Hesitancy Among Parents of Newborns

Interventions

BEHAVIORAL

PACV survey

BEHAVIORAL

Placebo survey

Sponsors & Collaborators

  • Seattle Children's Hospital

    collaborator OTHER
  • Baylor College of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04450940 on ClinicalTrials.gov